File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.bone.2011.08.031
- Scopus: eid_2-s2.0-81355127486
- PMID: 21925296
- WOS: WOS:000297663500021
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin
Title | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin | ||||||||
---|---|---|---|---|---|---|---|---|---|
Authors | |||||||||
Keywords | Osteoblasts Osteoclasts Osteoporosis Osteoprotegerin Strontium | ||||||||
Issue Date | 2011 | ||||||||
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/bone | ||||||||
Citation | Bone, 2011, v. 49 n. 6, p. 1290-1298 How to Cite? | ||||||||
Abstract | BACKGROUND: The mechanism for the uncoupling effects of Sr on bone remains to be evaluated. Osteoblasts play important roles in osteoclastogenesis through regulating receptor activated nuclear factor kappa B (RANK) ligand (RANKL) and osteoprotegerin (OPG) expression. We hypothesize that OPG plays an important role in the cross-talk between osteoclasts and osteoblasts in response to Sr treatment. MATERIALS AND METHODS: MC3T3E1 cells were treated with Sr chloride (0-3 mM) and conditioned media were collected at 24h after the treatment. The effect of conditioned media on osteoclastogenesis was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and bone resorption pits analysis. OPG and RANKL mRNA expressions in osteoblastic cells and protein secretion in the conditioned media were analyzed with real-time PCR and ELISA assay, respectively. The role of OPG in Sr-mediated inhibition of osteoclastogenesis was further evaluated with anti-OPG antibody in pre-osteoclastic cells. The role of OPG in Sr-mediated uncoupling effects on osteoporotic bone was evaluated by an animal study. Ovariectomized rats were oral administrated with vehicle or Sr chloride for two months supplemented with anti-IgG antibody (control) or anti-OPG antibody. The effects of OPG neutralization after Sr treatment on bone metabolism were analyzed by microCT, bone histomorphometry and biochemical analysis. RESULTS: The conditioned media derived from Sr-treated osteoblastic cells exerted a dose-dependent inhibitory effect on osteoclastic differentiation and resorptive activity in pre-osteoclastic cells. OPG mRNA expression and protein secretion in osteoblastic cells were significantly increased after Sr treatment. Neutralization with anti-OPG antibody abolished the inhibitory effect of conditioned media on RANKL-induced osteoclastogenesis. The uncoupling effects of Sr treatment on trabecular bone were evidenced by greater bone volume and trabecular number, greater osteoid surface and bone formation rate, while less osteoclast surface. These effects were attenuated by the OPG neutralization by anti-OPG antibody injection. CONCLUSION: The evidences from the in vitro and in vivo studies suggested that OPG played an important role in the uncoupling effect of Sr on bone metabolism, possibly by acting as a cross-talk molecule between osteoclasts and osteoblasts in response to Sr treatment. | ||||||||
Persistent Identifier | http://hdl.handle.net/10722/143128 | ||||||||
ISSN | 2023 Impact Factor: 3.5 2023 SCImago Journal Rankings: 1.179 | ||||||||
ISI Accession Number ID |
Funding Information: This study was supported by the Innovation and Technology Fund (ITF; Project ref. no. GHP/009/06), Hong Kong Research Grants Council (RGC) Grant 714908 and National Institutes of Health (R01 AR051376). | ||||||||
References | |||||||||
Grants |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Peng, S | en_HK |
dc.contributor.author | Liu, XS | en_HK |
dc.contributor.author | Huang, S | en_HK |
dc.contributor.author | Li, Z | en_HK |
dc.contributor.author | Pan, H | en_HK |
dc.contributor.author | Zhen, W | en_HK |
dc.contributor.author | Luk, KDK | en_HK |
dc.contributor.author | Guo, XE | en_HK |
dc.contributor.author | Lu, WW | en_HK |
dc.date.accessioned | 2011-11-02T03:05:44Z | - |
dc.date.available | 2011-11-02T03:05:44Z | - |
dc.date.issued | 2011 | en_HK |
dc.identifier.citation | Bone, 2011, v. 49 n. 6, p. 1290-1298 | en_HK |
dc.identifier.issn | 8756-3282 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/143128 | - |
dc.description.abstract | BACKGROUND: The mechanism for the uncoupling effects of Sr on bone remains to be evaluated. Osteoblasts play important roles in osteoclastogenesis through regulating receptor activated nuclear factor kappa B (RANK) ligand (RANKL) and osteoprotegerin (OPG) expression. We hypothesize that OPG plays an important role in the cross-talk between osteoclasts and osteoblasts in response to Sr treatment. MATERIALS AND METHODS: MC3T3E1 cells were treated with Sr chloride (0-3 mM) and conditioned media were collected at 24h after the treatment. The effect of conditioned media on osteoclastogenesis was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and bone resorption pits analysis. OPG and RANKL mRNA expressions in osteoblastic cells and protein secretion in the conditioned media were analyzed with real-time PCR and ELISA assay, respectively. The role of OPG in Sr-mediated inhibition of osteoclastogenesis was further evaluated with anti-OPG antibody in pre-osteoclastic cells. The role of OPG in Sr-mediated uncoupling effects on osteoporotic bone was evaluated by an animal study. Ovariectomized rats were oral administrated with vehicle or Sr chloride for two months supplemented with anti-IgG antibody (control) or anti-OPG antibody. The effects of OPG neutralization after Sr treatment on bone metabolism were analyzed by microCT, bone histomorphometry and biochemical analysis. RESULTS: The conditioned media derived from Sr-treated osteoblastic cells exerted a dose-dependent inhibitory effect on osteoclastic differentiation and resorptive activity in pre-osteoclastic cells. OPG mRNA expression and protein secretion in osteoblastic cells were significantly increased after Sr treatment. Neutralization with anti-OPG antibody abolished the inhibitory effect of conditioned media on RANKL-induced osteoclastogenesis. The uncoupling effects of Sr treatment on trabecular bone were evidenced by greater bone volume and trabecular number, greater osteoid surface and bone formation rate, while less osteoclast surface. These effects were attenuated by the OPG neutralization by anti-OPG antibody injection. CONCLUSION: The evidences from the in vitro and in vivo studies suggested that OPG played an important role in the uncoupling effect of Sr on bone metabolism, possibly by acting as a cross-talk molecule between osteoclasts and osteoblasts in response to Sr treatment. | en_HK |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/bone | en_HK |
dc.relation.ispartof | Bone | en_HK |
dc.subject | Osteoblasts | - |
dc.subject | Osteoclasts | - |
dc.subject | Osteoporosis | - |
dc.subject | Osteoprotegerin | - |
dc.subject | Strontium | - |
dc.subject.mesh | Anabolic Agents - pharmacology | - |
dc.subject.mesh | Osteoblasts - drug effects - metabolism - pathology | - |
dc.subject.mesh | Osteoclasts - drug effects - metabolism - pathology | - |
dc.subject.mesh | Osteoprotegerin - genetics - metabolism | - |
dc.subject.mesh | Strontium - pharmacology - therapeutic use | - |
dc.title | The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Peng, S: songlin@hku.hk | en_HK |
dc.identifier.email | Li, Z: lizy@hku.hk | en_HK |
dc.identifier.email | Pan, H: haobo@hku.hk | en_HK |
dc.identifier.email | Zhen, W: spine.zhen@gmail.com | - |
dc.identifier.email | Luk, KDK: hcm21000@hku.hk | - |
dc.identifier.email | Lu, WW: wwlu@hku.hk | - |
dc.identifier.authority | Pan, H=rp01564 | en_HK |
dc.identifier.authority | Luk, KDK=rp00333 | en_HK |
dc.identifier.authority | Lu, WW=rp00411 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/j.bone.2011.08.031 | en_HK |
dc.identifier.pmid | 21925296 | - |
dc.identifier.scopus | eid_2-s2.0-81355127486 | en_HK |
dc.identifier.hkuros | 207343 | - |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-81355127486&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 49 | en_HK |
dc.identifier.issue | 6 | en_HK |
dc.identifier.spage | 1290 | en_HK |
dc.identifier.epage | 1298 | en_HK |
dc.identifier.isi | WOS:000297663500021 | - |
dc.publisher.place | United States | en_HK |
dc.relation.project | Optimization and commercialization of strontium containing bioactive bone cement for various orthopaedic applications | - |
dc.identifier.scopusauthorid | Lu, WW=7404215221 | en_HK |
dc.identifier.scopusauthorid | Guo, XE=35237105200 | en_HK |
dc.identifier.scopusauthorid | Luk, KDK=7201921573 | en_HK |
dc.identifier.scopusauthorid | Zhen, W=9044966900 | en_HK |
dc.identifier.scopusauthorid | Pan, H=7403295092 | en_HK |
dc.identifier.scopusauthorid | Li, Z=35784563200 | en_HK |
dc.identifier.scopusauthorid | Huang, S=54581004600 | en_HK |
dc.identifier.scopusauthorid | Liu, XS=50061438600 | en_HK |
dc.identifier.scopusauthorid | Peng, S=13402746900 | en_HK |
dc.identifier.issnl | 1873-2763 | - |